N (%)
Gender
Male / Female	26 (59.1%)/18 (40.9%)
Age
Median age	56 (21-71)
HCT-CI
0/1-2/≥3	19 (43%)/14 (32%)/11 (25%)
Hematological malignancies
Acute myeloid leukemia (AML)	24 (54.5%)
Acute lymphoblastic leukemia (ALL)	7 (15.9%)
Myelodysplastic syndrome (MDS)	5 (11.4%)
Hodgkin lymphoma (LH)	3 (6.8%)
Non-Hodgkin lymphoma LNH)	3 (6.8%)
Myelofibrosis	1 (2.3%)
Plasma cell leukemia (PCL)	1 (2.3%)
Recipient/donor CMV serology
Positive/positive	32 (72.7%)
Positive/negative	11 (25%)
Negative/negative	1 (2.3%)
Previous transplant
Autologous	9 (64.3%)
Allogeneic	5 (35.7%)
Disease status
First complete remission	15 (34.1%)
Second complete remission	8 (18.2%)
Third complete remission	2 (4.5%)
Partial remission	19 (43.2%)
Conditioning regimen
Myeloablative	41 (93.2%)
Reduced-intensity	3 (6.8%)
Donor gender
Male / Female	26 (59.1%)/18 (40.9%)
Donor age
Median age	35 (20-71)
ABO incompatibility
ABO compatible	30 (68.2%)
Minor incompatible	10 (22.7%)
Major incompatible	4 (9.1%)
Median number infused CD34 + /kg	6 x 106 (1.5 - 7.7)
Median number infused CD3 + /kg	238.8 x 106 (26.2 – 858)